Bovine High Mountain Disease Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: BFD80390F6D8EN
Market Monitor Global

Abstracts

Bovine high-mountain disease (BHMD) is also known as brisket disease which causes significant death loss, especially in calves. The bovine high-mountain disease is right heart failure which is generally caused due to hypoxic pulmonary hypertension at high altitudes.

This report contains market size and forecasts of Bovine High Mountain Disease Drug in Global, including the following market information:

Global Bovine High Mountain Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bovine High Mountain Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diuretics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bovine High Mountain Disease Drug include Zoetis, Bayer, Eli Lilly, Dechra Pharmaceuticals and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bovine High Mountain Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bovine High Mountain Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bovine High Mountain Disease Drug Market Segment Percentages, by Type, 2021 (%)

• Diuretics
• Antibiotics
• Appetite Stimulators
• Others

Global Bovine High Mountain Disease Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bovine High Mountain Disease Drug Market Segment Percentages, by Application, 2021 (%)

• Veterinary Hospitals
• Veterinary Clinics
• Others

Global Bovine High Mountain Disease Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bovine High Mountain Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bovine High Mountain Disease Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bovine High Mountain Disease Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Zoetis
• Bayer
• Eli Lilly
• Dechra Pharmaceuticals
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bovine High Mountain Disease Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bovine High Mountain Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BOVINE HIGH MOUNTAIN DISEASE DRUG OVERALL MARKET SIZE

2.1 Global Bovine High Mountain Disease Drug Market Size: 2021 VS 2028
2.2 Global Bovine High Mountain Disease Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bovine High Mountain Disease Drug Players in Global Market
3.2 Top Global Bovine High Mountain Disease Drug Companies Ranked by Revenue
3.3 Global Bovine High Mountain Disease Drug Revenue by Companies
3.4 Top 3 and Top 5 Bovine High Mountain Disease Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bovine High Mountain Disease Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bovine High Mountain Disease Drug Players in Global Market
  3.6.1 List of Global Tier 1 Bovine High Mountain Disease Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bovine High Mountain Disease Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bovine High Mountain Disease Drug Market Size Markets, 2021 & 2028
  4.1.2 Diuretics
  4.1.3 Antibiotics
  4.1.4 Appetite Stimulators
  4.1.5 Others
4.2 By Type - Global Bovine High Mountain Disease Drug Revenue & Forecasts
  4.2.1 By Type - Global Bovine High Mountain Disease Drug Revenue, 2017-2022
  4.2.2 By Type - Global Bovine High Mountain Disease Drug Revenue, 2023-2028
  4.2.3 By Type - Global Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bovine High Mountain Disease Drug Market Size, 2021 & 2028
  5.1.2 Veterinary Hospitals
  5.1.3 Veterinary Clinics
  5.1.4 Others
5.2 By Application - Global Bovine High Mountain Disease Drug Revenue & Forecasts
  5.2.1 By Application - Global Bovine High Mountain Disease Drug Revenue, 2017-2022
  5.2.2 By Application - Global Bovine High Mountain Disease Drug Revenue, 2023-2028
  5.2.3 By Application - Global Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bovine High Mountain Disease Drug Market Size, 2021 & 2028
6.2 By Region - Global Bovine High Mountain Disease Drug Revenue & Forecasts
  6.2.1 By Region - Global Bovine High Mountain Disease Drug Revenue, 2017-2022
  6.2.2 By Region - Global Bovine High Mountain Disease Drug Revenue, 2023-2028
  6.2.3 By Region - Global Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bovine High Mountain Disease Drug Revenue, 2017-2028
  6.3.2 US Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.3.3 Canada Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.3.4 Mexico Bovine High Mountain Disease Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bovine High Mountain Disease Drug Revenue, 2017-2028
  6.4.2 Germany Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.4.3 France Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.4.4 U.K. Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.4.5 Italy Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.4.6 Russia Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.4.8 Benelux Bovine High Mountain Disease Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bovine High Mountain Disease Drug Revenue, 2017-2028
  6.5.2 China Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.5.3 Japan Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.5.4 South Korea Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.5.6 India Bovine High Mountain Disease Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bovine High Mountain Disease Drug Revenue, 2017-2028
  6.6.2 Brazil Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.6.3 Argentina Bovine High Mountain Disease Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bovine High Mountain Disease Drug Revenue, 2017-2028
  6.7.2 Turkey Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.7.3 Israel Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Bovine High Mountain Disease Drug Market Size, 2017-2028
  6.7.5 UAE Bovine High Mountain Disease Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Zoetis
  7.1.1 Zoetis Corporate Summary
  7.1.2 Zoetis Business Overview
  7.1.3 Zoetis Bovine High Mountain Disease Drug Major Product Offerings
  7.1.4 Zoetis Bovine High Mountain Disease Drug Revenue in Global Market (2017-2022)
  7.1.5 Zoetis Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Bovine High Mountain Disease Drug Major Product Offerings
  7.2.4 Bayer Bovine High Mountain Disease Drug Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Bovine High Mountain Disease Drug Major Product Offerings
  7.3.4 Eli Lilly Bovine High Mountain Disease Drug Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Dechra Pharmaceuticals
  7.4.1 Dechra Pharmaceuticals Corporate Summary
  7.4.2 Dechra Pharmaceuticals Business Overview
  7.4.3 Dechra Pharmaceuticals Bovine High Mountain Disease Drug Major Product Offerings
  7.4.4 Dechra Pharmaceuticals Bovine High Mountain Disease Drug Revenue in Global Market (2017-2022)
  7.4.5 Dechra Pharmaceuticals Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Bovine High Mountain Disease Drug Major Product Offerings
  7.5.4 Merck Bovine High Mountain Disease Drug Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bovine High Mountain Disease Drug Market Opportunities & Trends in Global Market
Table 2. Bovine High Mountain Disease Drug Market Drivers in Global Market
Table 3. Bovine High Mountain Disease Drug Market Restraints in Global Market
Table 4. Key Players of Bovine High Mountain Disease Drug in Global Market
Table 5. Top Bovine High Mountain Disease Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bovine High Mountain Disease Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bovine High Mountain Disease Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bovine High Mountain Disease Drug Product Type
Table 9. List of Global Tier 1 Bovine High Mountain Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bovine High Mountain Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bovine High Mountain Disease Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bovine High Mountain Disease Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bovine High Mountain Disease Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bovine High Mountain Disease Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bovine High Mountain Disease Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bovine High Mountain Disease Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2023-2028
Table 30. Zoetis Corporate Summary
Table 31. Zoetis Bovine High Mountain Disease Drug Product Offerings
Table 32. Zoetis Bovine High Mountain Disease Drug Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Bovine High Mountain Disease Drug Product Offerings
Table 35. Bayer Bovine High Mountain Disease Drug Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Bovine High Mountain Disease Drug Product Offerings
Table 38. Eli Lilly Bovine High Mountain Disease Drug Revenue (US$, Mn), (2017-2022)
Table 39. Dechra Pharmaceuticals Corporate Summary
Table 40. Dechra Pharmaceuticals Bovine High Mountain Disease Drug Product Offerings
Table 41. Dechra Pharmaceuticals Bovine High Mountain Disease Drug Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Bovine High Mountain Disease Drug Product Offerings
Table 44. Merck Bovine High Mountain Disease Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bovine High Mountain Disease Drug Segment by Type in 2021
Figure 2. Bovine High Mountain Disease Drug Segment by Application in 2021
Figure 3. Global Bovine High Mountain Disease Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bovine High Mountain Disease Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bovine High Mountain Disease Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bovine High Mountain Disease Drug Revenue in 2021
Figure 8. By Type - Global Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 12. US Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 16. Germany Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 24. China Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bovine High Mountain Disease Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bovine High Mountain Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Zoetis Bovine High Mountain Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Bovine High Mountain Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Bovine High Mountain Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dechra Pharmaceuticals Bovine High Mountain Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Bovine High Mountain Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)